Literature DB >> 10522878

Myasthenia, thymoma, presynaptic antibodies, and a continuum of neuromuscular hyperexcitability.

S Vernino1, R G Auger, A M Emslie-Smith, C M Harper, V A Lennon.   

Abstract

BACKGROUND: Autoantibodies specific for the nicotinic acetylcholine receptor (AChR) of skeletal muscle impair neuromuscular transmission in myasthenia gravis (MG). Autoantibodies specific for alpha3 neuronal AChRs or voltage-gated potassium channels have been reported in patients with Isaacs syndrome, an acquired disorder of continuous muscle fiber activity characterized by neuromyotonia.
OBJECTIVE: To report the neuromuscular autoantibody profiles of three patients with a syndrome of MG and neuromuscular hyperexcitability.
RESULTS: All three patients reported here had clinical and electrophysiologic evidence of MG and neuromuscular hyperexcitability. None had neuromyotonia. Thymoma was proven in two patients and suspected in the third. One had MG and thymoma and subsequently developed cramp-fasciculation syndrome; MG and rippling muscle syndrome appeared simultaneously in the other two. All patients had muscle and neuronal AChR binding antibodies and striational antibodies. Only one had antibodies reactive with alpha-dendrotoxin-complexed potassium channels.
CONCLUSIONS: The coexistence of cramp-fasciculation syndrome and acquired rippling muscle syndrome with MG, thymoma, and neuronal AChR autoantibodies suggests that there is a continuum of autoimmune neuromuscular hyperexcitability disorders related pathogenically to Isaacs syndrome. Manifestations of neuromuscular hyperexcitability may be altered and less apparent in the context of MG because of the coexisting defect of neuromuscular transmission.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10522878     DOI: 10.1212/wnl.53.6.1233

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Acquired rippling muscle disease associated with mild myasthenia gravis: a case report.

Authors:  Sander M van Schaik; V I H Kwa; A J van der Kooi
Journal:  J Neurol       Date:  2009-03-07       Impact factor: 4.849

2.  Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis.

Authors:  Estefanía Torres-Vega; Nuria Mancheño; Arantxa Cebrián-Silla; Vicente Herranz-Pérez; María J Chumillas; Germán Moris; Bastien Joubert; Jérôme Honnorat; Teresa Sevilla; Juan J Vílchez; Josep Dalmau; Francesc Graus; José Manuel García-Verdugo; Luis Bataller
Journal:  Neurology       Date:  2017-03-01       Impact factor: 9.910

3.  Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study.

Authors:  M Gastaldi; A De Rosa; M Maestri; E Zardini; S Scaranzin; M Guida; P Borrelli; O E Ferraro; V Lampasona; R Furlan; S R Irani; P Waters; B Lang; A Vincent; E Marchioni; R Ricciardi; D Franciotta
Journal:  Eur J Neurol       Date:  2019-03-25       Impact factor: 6.089

4.  Rippling Muscle Disease with Irregular Toe Jerks and Anti-acetylcholine Receptor Antibodies: Remission after Extended Thymectomy.

Authors:  Nanaka Yamaguchi; Shunichi Matsuda; Jun Matsumoto; Yoshikazu Ugawa; Jun Shimizu; Tatsushi Toda; Masahiro Sonoo; Toshihiro Yoshizawa
Journal:  Intern Med       Date:  2021-10-19       Impact factor: 1.282

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.